NUKL:XETRA:XETRA-VanEck Uranium and Nuclear Technologies UCITS ETF A USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 26.595

Change

0.00 (0.00)%

Market Cap

USD 0.07B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.32 (-0.63%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.67%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.16 (-0.59%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.18 (-0.64%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.16 (-0.68%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.22 (-0.80%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.52%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.04%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.31 (-0.62%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.50 (-0.10%)

USD 80.38B

ETFs Containing NUKL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.21% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.21% 95% A 92% A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.07B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.